Author:
Schneble Erika,Clifton G. Travis,Hale Diane F.,Peoples George E.
Reference114 articles.
1. Rosenberg SA (2004) Shedding light on immunotherapy for cancer. N Engl J Med 350:1461–1463
2. Kantoff PW, Higano CS, Shore ND, Berger ER et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411–422
3. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723
4. Robert C, Long GV, Brady B, Dutriaux C, Maio M et al (2014) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320–330
5. Alexander M. Eggermont VC-S, Grob JJ, Dummer R et al (2014) Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial. J Clin Oncol 32:5s
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献